IP Library Granted Patent US 7,921,848
Granted Patent B2
US 7,921,848 · App. 10/641,333 · Granted Apr 12, 2011

Contraceptive transcervical fallopian tube occlusion devices and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,921,848
App. No.
10/641,333
Granted
Apr 12, 2011
Kind
B2
Abstract

The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or a copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has a helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization is effected by passing a current through the resilient structure to the tubal walls.

Claims (26)

1. A device for occluding a reproductive body lumen, comprising:

an open-walled outer tubular member having a first end, a second end, a lumen extending therein;

an inner member extending through the lumen and surrounded by the open-walled outer tubular member;

a tissue ingrowth supporting member radially disposed between an inner surface of the open-walled outer tubular member and an outer surface of the inner member to support tissue ingrowth to thereby permanently occlude the body lumen; and

a material disposed over the inner member to provide immediate prevention of conception.

2. The device of claim 1 , wherein the material comprises a copper material.

3. The device of claim 2 , wherein the copper material comprises an alloy.

4. The device of claim 2 , wherein the copper material comprises a copper wire, a copper bead, or a copper coating.

5. The device of claim 1 , wherein the material comprises a spermicide.

6. An intrafallopian contraceptive system, comprising:

an open-walled outer member surrounding an inner member, and a tissue ingrowth promoting member radially disposed between an inner surface of the open-walled outer member and an outer surface of the inner member to occlude a fallopian tube for preventing conception; and

a material formed over the inner member to provide immediate prevention of conception.

7. The intrafallopian contraceptive system of claim 6 , wherein the material is a contraceptive to prevent conception.

8. The intrafallopian contraceptive system of claim 7 , wherein the contraceptive is copper.

9. The intrafallopian contraceptive system of claim 8 , wherein the copper is released at a release rate related to the surface area and volume of copper over the inner member.

10. The intrafallopian contraceptive system of claim 9 , wherein the release rate of copper is about 25 micrograms per day.

11. The intrafallopian contraceptive system of claim 7 , wherein the contraceptive is a spermicide.

12. A contraceptive device for use in a fallopian tube having a tubal wall, the contraceptive device comprising:

a stent-shape tubular retention structure adapted to radially expand to engage the tubal wall of the fallopian;

an inner member extending through and surrounded by the stent-shape tubular retention structure;

a tissue ingrowth supporting member radially disposed between an inner surface of the stent-shape tubular retention structure and an outer surface of the inner member to cause occlusion of the fallopian tube for preventing conception; and

a material formed over the inner member to provide immediate prevention of conception once the contraceptive device has been inserted into the fallopian tube.

13. The contraceptive device of claim 12 , wherein the stent-shape tubular retention structure comprises a slotted structure, the slotted structure comprising a Malecott retention structure or a braided filament retention structure.

14. The contraceptive device of claim 12 , further comprising a latching mechanism to prevent collapse of the stent-shape tubular retention structure once forcibly expanded.

15. The contraceptive device of claim 12 , wherein the stent-shape tubular retention structure is self-expanding.

16. The contraceptive device of claim 12 , wherein the tissue ingrowth supporting member is within an inner surface and outside of an outer surface of the stent-shape tubular retention structure.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2015
From: BAYER ESSURE INC.
To: BAYER HEALTHCARE LLC
Reel/Frame 036283/0050 →
CHANGE OF NAME Recorded Jan 16, 2014
From: CONCEPTUS, INC.
To: BAYER ESSURE INC.
Reel/Frame 032075/0466 →
RELEASE OF SECURITY INTEREST Recorded Apr 19, 2013
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: CONCEPTUS, INC.
Reel/Frame 030249/0431 →
SECURITY AGREEMENT Recorded Aug 26, 2011
From: CONCEPTUS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 026817/0493 →